| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |